AB Science S.A. Logo

AB Science S.A. (A8D)

FSX

Currency in EUR
0.6400
-0.05 (-7.38%)

Real-time Data

06:00 AM

Day's Range

0.6400
0.6400

52 wk Range

0.6400
1.60

Overview - A8D - AB Science S.A.

Key Statistics

Valuation

Enterprise Value

57.97M

P/E (Trailing)

‪-23.60‬

Price / Sales (TTM)

‪60.18‬

EV / EBITDA

‪77.81‬

Profitability

Profit Margin

‪-132.62%‬

Operating Margin

‪510.92%‬

Return on Assets

‪1.67%‬

Return on Equity

‪9.05%‬

Ownership

Shares Outstanding

66.36M

Float

18.11M

Held by Insiders

‪47.70%‬

Held by Institutions

‪0.0030%‬

Price stats

Beta

‪1.16‬

50-Day Avg

‪0.7237‬

200-Day Avg

‪1.09‬

Dividends

Payout Ratio

‪0.00%‬

Peers - A8D - AB Science S.A.

Peer Comparison

Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.

Profile Summary - A8D - AB Science S.A.

About

AB Science S.A. is a clinical-stage pharmaceutical company headquartered in Paris, France, founded in 2001. It specializes in the research, design, development, and marketing of innovative drugs targeting diseases with high unmet medical needs, particularly in oncology, inflammatory diseases, and neurological…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees28
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.